News
ReNeuron's latest press releases
ReNeuron presents key pre-clinical efficacy data with ReN009 stem cell therapy at leading UK diabetes conference. 03/03/10
Guildford, UK, 3 March 2010: ReNeuron Group plc (LSE: RENE.L) today announces further positive pre-clinical efficacy data with its ReN009 stem cell …
Read articleReNeuron announces fundraising. 22/02/10
Guildford, UK, 22 February 2010: ReNeuron Group plc (LSE: RENE.L) today announces that it has raised approximately £4.7 million, before expenses,…
ReNeuron and Schepens Eye Research Institute receive unrestricted industrial grant to support US retinal stem cell collaboration . 19/02/10
Guildford, UK, 18 February 2010: ReNeuron Group plc (LSE: RENE.L) today announces that its ongoing US collaboration with the Schepens Eye Research …
ReNeuron receives final regulatory approval to commence landmark stroke clinical trial in UK. 10/02/10
Guildford, UK, 10 February 2010: ReNeuron Group plc (LSE: RENE.L) today announces that the UK Gene Therapy Advisory Committee (GTAC) has given a full …
Clinical Advisory Board appointments. 01/02/10
Guildford, UK, 1 February 2010: ReNeuron Group plc (LSE: RENE.L) today announces the appointment of four opinion-leading clinicians to its newly-…
Regulatory Update. 28/01/10
Guildford, UK, 28 January 2010: ReNeuron Group plc (LSE: RENE.L) today provides a regulatory update regarding its ReN001 stem cell therapy for stroke.…
Office of Life Sciences. 27/01/10
Guildford, UK, 27 January 2010: ReNeuron Group plc (LSE: RENE.L) welcomes yesterday’s launch of the “Life Sciences 2010: Delivering the …
Regulatory Update. 11/01/10
Guildford, UK, 11 January 2010: ReNeuron Group plc (LSE: RENE.L) today provides a regulatory update regarding its ReN001 stem cell therapy for stroke …
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 >>If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.
Top of page